Medtronic is spinning off its diabetes care segment and focusing on core growth areas

From Yahoo Finance: 2025-05-31 07:45:00

Medtronic’s diabetes care segment outpaced overall business growth, prompting the decision to spin it off into a separate entity. Despite this, Medtronic has various growth opportunities and a strong dividend program. The diabetes care unit, with products like the MiniMed 780G insulin pump and CGM systems, was a key revenue driver. However, Medtronic announced plans to separate the unit to focus on core growth areas. While losing a fast-growing segment, Medtronic remains a robust company with a long-standing dividend increase streak. The company is seeking U.S. clearance for its Hugo robotic-assisted surgery system, which could open up significant opportunities in the medical field. Despite the spin-off, Medtronic continues to be a top pick for long-term investors.

Read more: Does This Move Make Medtronic Stock a Buy?